Exponent, Inc. (NASDAQ:EXPO) Shares Sold by Oppenheimer Asset Management Inc.

Oppenheimer Asset Management Inc. decreased its position in shares of Exponent, Inc. (NASDAQ:EXPOFree Report) by 2.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,620 shares of the business services provider’s stock after selling 942 shares during the period. Oppenheimer Asset Management Inc. owned 0.08% of Exponent worth $4,567,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in EXPO. Inspire Advisors LLC grew its stake in shares of Exponent by 1.3% in the 2nd quarter. Inspire Advisors LLC now owns 7,615 shares of the business services provider’s stock worth $724,000 after purchasing an additional 98 shares during the last quarter. Caprock Group LLC grew its position in Exponent by 4.2% in the second quarter. Caprock Group LLC now owns 3,296 shares of the business services provider’s stock worth $314,000 after buying an additional 134 shares during the last quarter. GAMMA Investing LLC grew its position in Exponent by 67.7% in the second quarter. GAMMA Investing LLC now owns 379 shares of the business services provider’s stock worth $36,000 after buying an additional 153 shares during the last quarter. Raymond James Trust N.A. increased its holdings in shares of Exponent by 2.8% in the second quarter. Raymond James Trust N.A. now owns 6,230 shares of the business services provider’s stock valued at $593,000 after buying an additional 172 shares in the last quarter. Finally, Natixis Investment Managers International lifted its position in shares of Exponent by 18.5% during the 1st quarter. Natixis Investment Managers International now owns 1,138 shares of the business services provider’s stock valued at $94,000 after acquiring an additional 178 shares during the last quarter. 92.37% of the stock is currently owned by institutional investors and hedge funds.

Exponent Trading Down 1.2 %

Shares of NASDAQ:EXPO opened at $97.40 on Friday. The firm has a market cap of $4.94 billion, a price-to-earnings ratio of 47.05 and a beta of 0.69. Exponent, Inc. has a 1 year low of $68.70 and a 1 year high of $115.75. The business has a fifty day simple moving average of $107.23 and a 200 day simple moving average of $101.97.

Exponent Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 20th. Shareholders of record on Friday, December 6th will be given a $0.28 dividend. This represents a $1.12 annualized dividend and a yield of 1.15%. The ex-dividend date of this dividend is Friday, December 6th. Exponent’s dividend payout ratio is 54.11%.

Analyst Ratings Changes

Separately, Truist Financial reaffirmed a “buy” rating and set a $120.00 price objective (up from $100.00) on shares of Exponent in a research note on Friday, July 26th.

Read Our Latest Research Report on EXPO

Insider Transactions at Exponent

In related news, Director Carol Lindstrom sold 1,039 shares of the firm’s stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $96.32, for a total value of $100,076.48. Following the transaction, the director now directly owns 5,871 shares of the company’s stock, valued at approximately $565,494.72. This trade represents a 15.04 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Paul R. Johnston sold 14,000 shares of the stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $104.60, for a total value of $1,464,400.00. Following the transaction, the director now owns 80,742 shares in the company, valued at approximately $8,445,613.20. This trade represents a 14.78 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 22,039 shares of company stock worth $2,291,286 in the last 90 days. 2.10% of the stock is owned by insiders.

About Exponent

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Read More

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.